References analysis of the Wikipedia article "Alpha blocker" in the English version

archive.org

doi.org

Bousquet P, Schwartz J (May 1983). "Alpha-adrenergic drugs. Pharmacological tools for the study of the central vasomotor control". Biochemical Pharmacology. 32 (9): 1459–1465. doi:10.1016/0006-2952(83)90466-5. PMID 6134533.

McKeage K, Plosker GL (2002-03-01). "Alfuzosin: a review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia". Drugs. 62 (4): 633–653. doi:10.2165/00003495-200262040-00009. PMID 11893233. S2CID 250307179.

Nash DT (November 1990). "Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism". Clinical Cardiology. 13 (11): 764–772. doi:10.1002/clc.4960131104. PMID 1980236. S2CID 24619863.

Green B (July 2014). "Prazosin in the treatment of PTSD". Journal of Psychiatric Practice. 20 (4): 253–259. doi:10.1097/01.pra.0000452561.98286.1e. PMID 25036580. S2CID 40069887.

Lepor H, Henry D, Laddu AR (1991-01-01). "The efficacy and safety of terazosin for the treatment of symptomatic BPH". The Prostate. 18 (4): 345–355. doi:10.1002/pros.2990180408. PMID 1711689. S2CID 37160206.

Michel MC (2010). "The Pharmacological Profile of the α1A-Adrenoceptor Antagonist Silodosin". European Urology Supplements. 9 (4): 486–490. doi:10.1016/j.eursup.2010.03.006.

Charney DS, Woods SW, Goodman WK, Heninger GR (August 1987). "Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks". The American Journal of Psychiatry. 144 (8): 1030–1036. doi:10.1176/ajp.144.8.1030. PMID 3037926.

Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinhal V, et al. (September 1997). "Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group". Journal of Cardiac Failure. 3 (3): 173–179. doi:10.1016/s1071-9164(97)90013-0. PMID 9330125.

Roehrborn CG, Schwinn DA (March 2004). "Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia". The Journal of Urology. 171 (3): 1029–1035. doi:10.1097/01.ju.0000097026.43866.cc. PMID 14767264.

Messerli FH (November 2001). "Doxazosin and congestive heart failure". Journal of the American College of Cardiology. 38 (5): 1295–1296. doi:10.1016/s0735-1097(01)01534-0. PMID 11691497.

Ernst E, Pittler MH (February 1998). "Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials". The Journal of Urology. 159 (2): 433–436. doi:10.1016/s0022-5347(01)63942-9. PMID 9649257.

Laurent S (October 2017). "Antihypertensive drugs". Pharmacological Research. 124: 116–125. doi:10.1016/j.phrs.2017.07.026. PMID 28780421. S2CID 251991.

Brogden RN, Heel RC, Speight TM, Avery GS (April 1978). "Labetalol: a review of its pharmacology and therapeutic use in hypertension". Drugs. 15 (4): 251–270. doi:10.2165/00003495-197815040-00002. PMID 25757. S2CID 42161040.

Bravo EL (September 2002). "Pheochromocytoma: an approach to antihypertensive management". Annals of the New York Academy of Sciences. 970 (1): 1–10. Bibcode:2002NYASA.970....1B. doi:10.1111/j.1749-6632.2002.tb04408.x. PMID 12381537. S2CID 222084372.

Das S, Kumar P, Kiran U, Airan B (January 2017). "Alpha blockers: A relook at phenoxybenzamine". Journal of the Practice of Cardiovascular Sciences. 3 (1): 11. doi:10.4103/jpcs.jpcs_42_16.

Bristow MR (February 2000). "beta-adrenergic receptor blockade in chronic heart failure". Circulation. 101 (5): 558–569. doi:10.1161/01.CIR.101.5.558. PMID 10662755.

Lue TF (June 2000). "Erectile dysfunction". The New England Journal of Medicine. 342 (24): 1802–1813. doi:10.1056/nejm200006153422407. PMID 10853004.

Carson CC, ed. (2007). "A Description of the Pioneering Work That Led to the First Approved Agents for ED: Giles Brindley, the Needle, and the Penis (Phenoxybenzamine)". Key Clinical Trials in Erectile Dysfunction. London: Springer. pp. 4–7. doi:10.1007/978-1-84628-428-1_2. ISBN 978-1-84628-428-1.

Bakst R, Merola JF, Franks AG, Sanchez M (October 2008). "Raynaud's phenomenon: pathogenesis and management". Journal of the American Academy of Dermatology. 59 (4): 633–653. doi:10.1016/j.jaad.2008.06.004. PMID 18656283.

Koola MM, Varghese SP, Fawcett JA (February 2014). "High-dose prazosin for the treatment of post-traumatic stress disorder". Therapeutic Advances in Psychopharmacology. 4 (1): 43–47. doi:10.1177/2045125313500982. PMC 3896131. PMID 24490030.

Hodsman GP, Isles CG, Murray GD, Usherwood TP, Webb DJ, Robertson JI (March 1983). "Factors related to first dose hypotensive effect of captopril: prediction and treatment". British Medical Journal. 286 (6368): 832–834. doi:10.1136/bmj.286.6368.832. PMC 1547159. PMID 6403103.

Elliott HL (2007). "Alpha Adrenoreceptor Antagonists". Comprehensive Hypertension. pp. 1019–1025. doi:10.1016/b978-0-323-03961-1.50085-4. ISBN 9780323039611.

"Alpha-blockers: their properties and use in hypertension". Prescriber. 22 (13–14): 38–39. July 2011. doi:10.1002/psb.779.

Debruyne FM (November 2000). "Alpha blockers: are all created equal?". Urology. 56 (5 Suppl 1): 20–22. doi:10.1016/s0090-4295(00)00744-5. PMID 11074198.

Pierce KL, Premont RT, Lefkowitz RJ (September 2002). "Seven-transmembrane receptors". Nature Reviews. Molecular Cell Biology. 3 (9): 639–650. doi:10.1038/nrm908. PMID 12209124. S2CID 23659116.

Bylund DB (February 1992). "Subtypes of alpha 1- and alpha 2-adrenergic receptors". FASEB Journal. 6 (3): 832–839. doi:10.1096/fasebj.6.3.1346768. PMID 1346768. S2CID 83827013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Green B (July 2014). "Prazosin in the treatment of PTSD". Journal of Psychiatric Practice. 20 (4): 253–259. doi:10.1097/01.pra.0000452561.98286.1e. PMID 25036580. S2CID 40069887.

Narayan P, Tunuguntla HS (2005). "Long-term efficacy and safety of tamsulosin for benign prostatic hyperplasia". Reviews in Urology. 7 (Suppl 4): S42–S48. PMC 1477608. PMID 16986054.

Richards DA (August 1976). "Pharmacological effects of labetalol in man". British Journal of Clinical Pharmacology. 3 (4 Suppl 3): 721–723. PMID 10949.

Messerli FH (November 2001). "Doxazosin and congestive heart failure". Journal of the American College of Cardiology. 38 (5): 1295–1296. doi:10.1016/s0735-1097(01)01534-0. PMID 11691497.

Laurent S (October 2017). "Antihypertensive drugs". Pharmacological Research. 124: 116–125. doi:10.1016/j.phrs.2017.07.026. PMID 28780421. S2CID 251991.

Bristow MR (February 2000). "beta-adrenergic receptor blockade in chronic heart failure". Circulation. 101 (5): 558–569. doi:10.1161/01.CIR.101.5.558. PMID 10662755.

Lue TF (June 2000). "Erectile dysfunction". The New England Journal of Medicine. 342 (24): 1802–1813. doi:10.1056/nejm200006153422407. PMID 10853004.

Chapple CR (January 1996). "Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience". European Urology. 29 (2): 129–144. PMID 8647139.

Lepor H, Lepor NE, Hill LA, Trohman RG (Spring 2008). "The QT Interval and Selection of Alpha-Blockers for Benign Prostatic Hyperplasia". Reviews in Urology. 10 (2): 85–91. PMC 2483321. PMID 18660858.

Lepor H (Fall 2007). "Alpha blockers for the treatment of benign prostatic hyperplasia". Reviews in Urology. 9 (4): 181–190. PMC 2213889. PMID 18231614.

Debruyne FM (November 2000). "Alpha blockers: are all created equal?". Urology. 56 (5 Suppl 1): 20–22. doi:10.1016/s0090-4295(00)00744-5. PMID 11074198.

Pierce KL, Premont RT, Lefkowitz RJ (September 2002). "Seven-transmembrane receptors". Nature Reviews. Molecular Cell Biology. 3 (9): 639–650. doi:10.1038/nrm908. PMID 12209124. S2CID 23659116.

Bylund DB (February 1992). "Subtypes of alpha 1- and alpha 2-adrenergic receptors". FASEB Journal. 6 (3): 832–839. doi:10.1096/fasebj.6.3.1346768. PMID 1346768. S2CID 83827013.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

Green B (July 2014). "Prazosin in the treatment of PTSD". Journal of Psychiatric Practice. 20 (4): 253–259. doi:10.1097/01.pra.0000452561.98286.1e. PMID 25036580. S2CID 40069887.

Laurent S (October 2017). "Antihypertensive drugs". Pharmacological Research. 124: 116–125. doi:10.1016/j.phrs.2017.07.026. PMID 28780421. S2CID 251991.

Pierce KL, Premont RT, Lefkowitz RJ (September 2002). "Seven-transmembrane receptors". Nature Reviews. Molecular Cell Biology. 3 (9): 639–650. doi:10.1038/nrm908. PMID 12209124. S2CID 23659116.

Bylund DB (February 1992). "Subtypes of alpha 1- and alpha 2-adrenergic receptors". FASEB Journal. 6 (3): 832–839. doi:10.1096/fasebj.6.3.1346768. PMID 1346768. S2CID 83827013.

Alpha blocker (English Wikipedia)

archive.org

bhsoc.org

cvpharmacology.com

doi.org

drugs.com

harvard.edu

ui.adsabs.harvard.edu

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

patient.info

semanticscholar.org

api.semanticscholar.org

web.archive.org

worldcat.org

search.worldcat.org